1 - 25 of 10
Number of results to display per page
TitleCreatorRelation Is Part Of
1 Good Therapies Gone Bad - What the Neuro-Ophthalmologist Needs to KnowFiona Costello, MD, FRCPNANOS Annual Meeting 2023: Neuroimmunology: https://novel.utah.edu/collection/NAM/toc/
2 Good Therapies Gone Bad - What the Neuro-Ophthalmologist Needs to KnowFiona Costello, MD, FRCPNANOS Annual Meeting 2023: Neuroimmunology
3 Idiopathic Intracranial Hypertension: Management ChallengesSusan P. Mollan, FRCOphthNANOS Annual Meeting 2023: State of the Art - Global Perspectives
4 Optic Nerve Hypoplasia: Controversies in EmbryogenesisMichael Brodsky, MDNANOS Annual Meeting 2023: Insight Into Neuroanatomy: Learning From Pediatric Neuro-Ophthalmic Disorders
5 A Randomized Controlled, Trial of the GLP-1 Receptor Agonist Exenatide in Idiopathic Intracranial HypertensionJames Mitchell, Major RAMCNANOS Annual Meeting 2022: Scientific Platform Session II
6 Mitochondrial Genetics - From Genes to Disease MechanismsValerio Carelli, MD, PhDNANOS Annual Meeting 2022: Mitochondrial Disorders: More Than the Optic Nerve
7 AION Precipitants (PDF)Anthony Arnold, MD, Clare Fraser, FRANZCO, Howard Pomeranz, MD, PhD, Helen Danesh-Meyer, MD, PhDNANOS Annual Meeting 2020: Hot Topics
8 OCT and Neurodegeneration of Alzheimer's Disease and Parkinson's Disease (abstract)Victoria S. Pelak, MDNANOS Annual Meeting 2017: Hot Topics in OCT
9 A Novel Mechanism for the Central Nervous System Transit of Aquaporin-4 Autoantibody in Neuromyelitis Optica (abstract)Jeffrey Bennett, Fumitaka Shimizu, Kristin Schaller, Gregory Owens, Anne Cotleur, Debra Kellner, Yukio Takeshita, Birgit Obermeier, Thomas Kryzer, Yasuteru Sano, Takashi Kanda, Vanda Lennon, Richard RansohoffNANOS Annual Meeting 2017: Scientific Platform II
10 Side Effects of New Immuno-Modulators (abstract)Ore-ofe Oluwaseun Adesina, MDNANOS 2017: Neuro-Ophthalmologic Side Effects of More Recently Used Medications in Treating Cancer, Rheumatologic Disorders, and Multiple Sclerosis
1 - 25 of 10